Virksomhedsstatus | NORMAL. |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 30.12.2003 (7584
dage). |
Ingen historik.
Branche | Dyrlæger (750000). |
Sidst opdateret den 26.05.2014 og
angivet som gældende fra 26.05.2014 (3784
dage). |
Historik | Start | Stop |
---|
Dyrlæger (750000) | 26.05.2014 | |
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900) | 01.01.2008 | 25.05.2014 |
Forskning og udvikling inden for naturvidenskab og teknik (731000) | 30.12.2003 | 31.12.2007 |
Revisionfravalgt | false. |
Sidst opdateret den 11.03.2015 og
angivet som gældende fra 30.12.2003 (7584
dage). |
Ingen historik.
Revisor | KPMG P/S |
Sidst opdateret den 13.01.2017 og
angivet som gældende fra 09.01.2017 (2825
dage). |
Kontaktoplysninger | vivian-dorenbos@idexx.com. |
Sidst opdateret den 12.10.2017 og
angivet som gældende fra 12.10.2017 (2549
dage). |
Historik | Start | Stop |
---|
vivian-dorenbos@idexx.com | 12.10.2017 | |
valerie-maguire@idexx.com | 01.08.2012 | 11.10.2017 |
Ingen nuværende registrering.
Ingen historik.
Navne | IDEXX LABORATORIES DANMARK ApS. |
Sidst opdateret den 01.08.2012 og
angivet som gældende fra 01.08.2012 (4447
dage). |
Historik | Start | Stop |
---|
IDEXX LABORATORIES DANMARK ApS | 01.08.2012 | |
IDEXX VET MED LAB ApS | 31.03.2010 | 31.07.2012 |
VET.MED.LAB. ApS | 30.12.2003 | 30.03.2010 |
Tegningsregel | Selskabets ledes af en af generalforsamlingen valgt direktion bestående af 1-5 medlemmer. Direktionen kan udstede fuldmagt til selskabets ansatte. Selskabet tegnes af en direktør alene. |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 01.08.2012 (4447
dage). |
Fortolkning
(4 tegningsmuligheder)
| 1 generalforsamlingen_valgt_direktion bestående |
medlemmer |
direktionen kan udstede fuldmagt til selskabets ansatte |
1 direktør |
Ingen historik.
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:KPMG Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:25578198
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Reporting class B
Grundlag for konklusion (revision):Basis for opinion We conducted our extended review in accordance with the Danish Business Authority's Assurance Standard for Small Enterprises and FSR – Danish Auditors' standard on extended review of financial statements prepared in accordance with the Danish Financial Statements Act. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibility for the extended review of the financial statements" section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):Conclusion We have performed an extended review of the financial statements of IDEXX Laboratories Danmark ApS for the financial year 1. January – 31. December 2023 comprising income statement, balance sheet, statement of changes in equity and notes, including the accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. Based on the work performed, it is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31. December 2023 and of the results of the Company's operations for the financial year 1. January – 31. December 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on the Management's review Management is responsible for the Management's review. Our conclusion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon. In connection with our extended review of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements, or our knowledge obtained during the extended review, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on the work we have performed; we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of the Management's review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.